Misplaced Pages

Lhermitte–Duclos disease

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Dysplastic cerebellar gangliocytoma)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Lhermitte–Duclos disease" – news · newspapers · books · scholar · JSTOR (July 2023) (Learn how and when to remove this message)
Medical condition
Lhermitte-Duclos disease (LDD)
Other namesDysplastic gangliocytoma of the cerebellum (DGC)
Lhermitte-Duclos disease histology
SpecialtyNeuro-oncology

Lhermitte–Duclos disease (LDD) (English: /ˌlɛərˈmiːtˌduːˈkloʊ/), also called dysplastic gangliocytoma of the cerebellum (DGC), is a rare, slowly growing tumor of the cerebellum, a gangliocytoma sometimes considered to be a hamartoma, characterized by diffuse hypertrophy of the granular layer of the cerebellum. It is often associated with Cowden syndrome. It was described by Jacques Jean Lhermitte and P. Duclos in 1920.

Signs and symptoms

Main clinical signs and symptoms include:

Patients with Lhermitte–Duclos disease and Cowden's syndrome may also have multiple growths on skin. The tumor, though benign, may cause neurological injury including abnormal movements.

MICROSCOPY (lhermitte-duclos disease) 1>Enlarged circumscribed cerebellar folia 2>internal granular layer is focally indistinct and is occupied by large ganglion cells 3>myelinated tracks in outer molecular layer 4>underlying white matter is atrophic and gliotic

Pathophysiology

In Lhermitte–Duclos disease, the cerebellar cortex loses its normal architecture, and forms a hamartoma in the cerebellar hemispheres. The tumors are usually found on the left cerebellar hemisphere, and consist of abnormal hypertrophic ganglion cells that are somewhat similar to Purkinje cells. The amount of white matter in the cerebellum is diminished. Like cowden syndrome, patients with Lhermitte–Duclos disease often have mutations in enzymes involved in the Akt/PKB signaling pathway, which plays a role in cell growth. Mutation in PTEN gene on chromosome no. 10q leads to increased activity of AKT and mTOR pathways, and patients should be tested for these mutations because they may be at risk of other tumors and cancers in other parts of the body.

Diagnosis

This section is empty. You can help by adding to it. (May 2017)

Treatment

Treatment is not needed in the asymptomatic patient. Symptomatic patients may benefit from surgical debulking of the tumor. Complete tumor removal is not usually needed and can be difficult due to the tumor location.

Epidemiology

Lhermitte–Duclos disease is a rare entity; approximately 222 cases of LDD have been reported in medical literature. Symptoms of the disease most commonly manifest in the third and fourth decades of life, although it may onset at any age. Men and women are equally affected, and there is not any apparent geographical pattern.

History

The disease was first described in 1920 by Lhermitte and Duclos.

See also

References

  1. Eng C (November 2000). "Will the real Cowden syndrome please stand up: revised diagnostic criteria". Journal of Medical Genetics. 37 (11): 828–830. doi:10.1136/jmg.37.11.828. PMC 1734465. PMID 11073535.
  2. Lhermitte J, Duclos P (1920). "Sur un ganglioneurome diffuse du cortex du cervelet". Bulletin de l'Association Française pour l'Étude du Cancer. 9. Paris: 99–107.
  3. "Cowden Syndrome". The Lecturio Medical Concept Library. Retrieved 10 July 2021.
  4. Robinson S, Cohen AR (January 2006). "Cowden disease and Lhermitte-Duclos disease: an update. Case report and review of the literature". Neurosurgical Focus. 20 (1): E6. doi:10.3171/foc.2006.20.1.7. PMID 16459996.
  5. ^ Kumar R, Vaid VK, Kalra SK (July 2007). "Lhermitte-Duclos disease". Child's Nervous System. 23 (7): 729–732. doi:10.1007/s00381-006-0271-8. PMID 17221273. S2CID 22190349.

External links

ClassificationD
External resources
Phakomatosis
Angiomatosis
Hamartoma
Neurofibromatosis
Other
Tumours of the nervous system
Endocrine
Sellar:
Other:
CNS
Neuroepithelial
(brain tumors,
spinal tumors)
Glioma
Astrocyte
Oligodendrocyte
Ependyma
Choroid plexus
Multiple/unknown
Mature
neuron
CNS embryonal tumors
Meninges
Hematopoietic
PNS:
Other
Note: Not all brain tumors are of nervous tissue, and not all nervous tissue tumors are in the brain (see brain metastasis).
Deficiencies of intracellular signaling peptides and proteins
GTP-binding protein regulators
GTPase-activating protein
Guanine nucleotide
exchange factor
G protein
Heterotrimeic
Monomeric
MAP kinase
Other kinase/phosphatase
Tyrosine kinase
Serine/threonine
kinase
Tyrosine
phosphatase
Signal transducing adaptor proteins
Other
See also intracellular signaling peptides and proteins
Categories: